Oxford Biomedica bags MHRA nod for two manufacturing suites
The move will provide access to the Oxford COVID-19 Vaccine Consortium for production of vaccine should trials prove successful
Read More
Tag: manufacturing sites
- MHRA approves new treatment for severe alopecia areata
- Aplagon doses first patient in phase 2a trial of APAC
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
